Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Failure of Sulphanilamide to Inhibit Calcification of Bone

Abstract

BENESCH and co-workers1 have reported almost complete absence of calcification in the bones of rat fœtuses at term, following administration of large doses of sulphanilamide and sulphapyridine to the mothers during the last seven to ten days of the gestation period. Their report was based upon haematoxylin-staining of decalcified bones, with the reservation that this method might not be reliable, and upon X-ray examination of the bones of the foetuses from sulphonamide-treated rats, no mention being made of control observations upon normal fœtuses. The results of observations upon mice were stated to be equivocal.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MILLER, Z., WALDMAN, J. & MCLEAN, F. Failure of Sulphanilamide to Inhibit Calcification of Bone. Nature 161, 273–274 (1948). https://doi.org/10.1038/161273b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/161273b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing